ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975